- Report
- March 2025
- 89 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- September 2023
- 185 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- January 2024
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2022
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- January 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- January 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- October 2023
- 146 Pages
Global
From €3353EUR$3,528USD£2,817GBP
€3945EUR$4,150USD£3,314GBP
- Report
- July 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
Single Cell Genome Sequencing (SCGS) is a biotechnology technique used to sequence the genomes of individual cells. It is a powerful tool for studying the genetic diversity of a population, as it allows researchers to analyze the genetic makeup of individual cells. SCGS can be used to study the genetic basis of diseases, to identify rare genetic variants, and to study the evolution of cells. It can also be used to study the genetic basis of drug resistance and to identify novel drug targets.
SCGS is a rapidly growing field, with many companies offering products and services. Examples include 10x Genomics, Illumina, Oxford Nanopore Technologies, Pacific Biosciences, and Thermo Fisher Scientific. These companies provide a range of products and services, from sequencing kits to bioinformatics software. Show Less Read more